Dataset Information

Novel C-2 Symmetric Molecules as ?-Glucosidase and ?-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.

ABSTRACT: A series of symmetrical salicylaldehyde-bishydrazine azo molecules, 5a-5h, have been synthesized, characterized by 1H-NMR and 13C-NMR, and evaluated for their in vitro ?-glucosidase and ?-amylase inhibitory activities. All the synthesized compounds efficiently inhibited both enzymes. Compound 5g was the most potent derivative in the series, and powerfully inhibited both ?-glucosidase and ?-amylase. The IC50 of 5g against ?-glucosidase was 0.35917 ± 0.0189 µM (standard acarbose IC50 = 6.109 ± 0.329 µM), and the IC50 value of 5g against ?-amylase was 0.4379 ± 0.0423 µM (standard acarbose IC50 = 33.178 ± 2.392 µM). The Lineweaver-Burk plot indicated that compound 5g is a competitive inhibitor of ?-glucosidase. The binding interactions of the most active analogues were confirmed through molecular docking studies. Docking studies showed that 5g interacts with the residues Trp690, Asp548, Arg425, and Glu426, which form hydrogen bonds to 5g with distances of 2.05, 2.20, 2.10 and 2.18 Å, respectively. All compounds showed high mutagenic and tumorigenic behaviors, and only 5e showed irritant properties. In addition, all the derivatives showed good antioxidant activities. The pharmacokinetic evaluation also revealed promising results.

SUBMITTER: Shahzad D

PROVIDER: S-EPMC6515238 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.

Shahzad Danish D Saeed Aamer A Larik Fayaz Ali FA Channar Pervaiz Ali PA Abbas Qamar Q Alajmi Mohamed F MF Arshad M Ifzan MI Erben Mauricio F MF Hassan Mubashir M Raza Hussain H Seo Sung-Yum SY El-Seedi Hesham R HR

Molecules (Basel, Switzerland) 20190417 8

A series of symmetrical salicylaldehyde-bishydrazine azo molecules, 5a-5h, have been synthesized, characterized by 1H-NMR and 13C-NMR, and evaluated for their in vitro α-glucosidase and α-amylase inhibitory activities. All the synthesized compounds efficiently inhibited both enzymes. Compound 5g was the most potent derivative in the series, and powerfully inhibited both α-glucosidase and α-amylase. The IC50 of 5g against α-glucosidase ...[more]

PMID: 30999646

Dataset Information

Novel C-2 Symmetric Molecules as ?-Glucosidase and ?-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.

Publications

Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Synthesis of amantadine clubbed <i>N</i>-aryl amino thiazoles as potent urease, α-amylase & α-glucosidase inhibitors, kinetic and molecular docking studies.
| S-EPMC10442672 | biostudies-literature

Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
| S-EPMC9609971 | biostudies-literature

Quinazolinone-1,2,3-triazole-acetamide conjugates as potent α-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study.
| S-EPMC10033893 | biostudies-literature

Design, Synthesis, In Silico Testing, and In Vitro Evaluation of Thiazolidinone-Based Benzothiazole Derivatives as Inhibitors of α-Amylase and α-Glucosidase.
| S-EPMC9610606 | biostudies-literature

Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
| S-EPMC9572811 | biostudies-literature

Hypoglycemic Efficacy of Docking Selected Natural Compounds against ?-Glucosidase and ?-Amylase.
| S-EPMC6225388 | biostudies-other

Momilactones A and B Are ?-Amylase and ?-Glucosidase Inhibitors.
| S-EPMC6385104 | biostudies-literature

Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors.
| S-EPMC6661812 | biostudies-literature

Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as ?-Glucosidase Inhibitors.
| S-EPMC6150375 | biostudies-other

Synthesis, <i>in vitro</i> inhibitory activity, kinetic study and molecular docking of novel <i>N</i>-alkyl-deoxynojirimycin derivatives as potential α-glucosidase inhibitors.
| S-EPMC7580737 | biostudies-literature